Bacterial endocarditis is a serious and potentially life-threatening infection of the inner lining of the heart chambers (endocardium) or heart valves. It occurs when bacteria enter the bloodstream and attach to damaged areas of the heart, forming infective masses known as vegetations. Common causative bacteria include Streptococcus and Staphylococcus species. Individuals with pre-existing heart conditions, such as damaged heart valves or congenital heart defects, are at an increased risk of developing bacterial endocarditis. The condition often presents with symptoms like fever, fatigue, chills, and heart murmurs. Diagnosis involves blood cultures and imaging studies like echocardiography. Bacterial endocarditis requires prompt and targeted antibiotic treatment to eliminate the infecting bacteria. In severe cases or when complications arise, surgical intervention may be necessary to repair or replace damaged heart valves. Preventive measures involve antibiotic prophylaxis before certain dental or medical procedures in individuals with high-risk conditions. However, recommendations for prophylaxis have evolved, and the decision is often based on individual patient factors. Timely diagnosis and appropriate management are crucial to improving outcomes and reducing the risk of complications associated with bacterial endocarditis.
Title : A promising novel approach to DNA vaccines
Khursheed Nadeem Anwer, IMUNON, United States
Title : Nanoscopic SubATVax™ adjuvanted vaccines against influenza A types H3N2, H1N1 and influenza type B for subcutaneous administration
David Craig Wright, D4 Labs, LLC, United States
Title : The importance of post-marketing surveillance and real-world data for a product to be successful
Regina Au, BioMarketing Insight, United States
Title : Prophylactic and molecular approaches for mitigating human influenza A viruses: i. Evaluating influenza vaccine effectiveness in the older population ii. Down-regulation of influenza virus genes with novel sirna-chimeric-ribozyme constructs
Madhu Khanna, University of Delhi, India
Title : Commensal bacteria drive B-cell lymphomagenesis in the setting of innate immunodeficiency
Ping Xie, Rutgers University, United States
Title : The role of immunity in the pathogenesis of SARS-COV-2 and in the protection generated by COVID-19 in different age groups
Ahmed Abdulazeez, BHRUT Trust, United Kingdom
Title : Establishing a platform method for physical appearance assessment of new parenteral pharmaceuticals
Ying Wan, Merck & Co., United States
Title : Evaluating the immunogenic impact of process impurities in mRNA vaccine production: Establishing integrated control strategies and specifications
Jesse Kuiper, Merck Research Laboratories, United States
Title : New biomarkers in leishmania major vaccine development
Negar Seyed, Pasteur Institute of Iran, Iran (Islamic Republic of)
Title : Advances in vaccines: Revolutionizing disease prevention
Delia Teresa Sponza, Dokuz Eylul University, Turkey